Skip to main content
. 2018 Aug 7;13(8):e0201434. doi: 10.1371/journal.pone.0201434

Table 2. Reference reader signal ratings vs pathology.

CJD (all types)a
n (%)
Not CJDb
n (%)
p value vCJD
n (%)
sCJD
n (%)
p value
n 118 82 32 75
Whole brain 68 (57.6) 44 (53.7) 11 (34.4) 47 (62.7)
Correctly identified by neuroradiologist 89 (75.4) 56 (68.3) 20 (62.5) 28 (37.3)
Brain atrophy 13 (11.0) 31 (37.8) <0.0001 0 (0.0) 11 (14.7) 0.032
White matter hyperintensities 16 (13.6) 39 (47.6) <0.0001 0 (0.0) 15 (20.0) 0.005
Caudate nucleus signal
Bright on T2 60 (50.9) 11 (13.4) <0.0001 16 (50.0) 39 (52.0) 1.000
Bright or possibly bright on T2 85 (72.0) 20 (24.4) <0.0001 24 (75.0) 54 (72.0) 0.816
Bright on PD 107 (90.7) 73 (89.0) 0.812 31 (96.9) 68 (90.7) 0.431
Bright or possibly bright on PD 111 (94.1) 76 (92.7) 0.774 32 (100.0) 70 (93.3) 0.319
Lentiform nucleus signal
Bright on T2 69 (58.5) 14 (17.1) <0.0001 20 (62.5) 43 (57.3) 0.672
Bright or possibly bright on T2 95 (80.5) 28 (34.2) <0.0001 29 (90.6) 58 (77.3) 0.174
Bright on PD 105 (89.0) 69 (84.2) 0.393 27 (84.4) 69 (92.0) 0.299
Bright or possibly bright on PD 112 (94.9) 75 (91.5) 0.388 31 (96.9) 71 (94.7) 1.000
Pulvinar signal
Bright on T2 38 (32.2) 6 (7.3) <0.0001 15 (46.9) 19 (25.3) 0.041
Bright or possibly bright on T2 53 (44.9) 9 (11.0) <0.0001 20 (62.5) 28 (37.3) 0.020
Bright on PD 89 (75.4) 50 (61.0) 0.042 30 (93.8) 54 (72.0) 0.011
Bright or possibly bright on PD 101 (85.6) 57 (69.5) 0.008 31 (96.9) 61 (81.3) 0.036
Pulvinar sign
Present on T2 8 (9.8) 3 (2.5) 0.530 6 (18.8) 2 (2.7) 0.009
Present or pulvinar signal same as putamen on T2 49 (41.5) 17 (20.7) 0.002 20 (62.5) 25 (33.3) 0.010
Present on PD 10 (8.5) 3 (3.7) 0.246 8 (25.0) 2 (2.7) 0.001
Present or pulvinar signal same as putamen on PD 91 (77.1) 49 (59.8) 0.012 29 (90.6) 55 (73.3) 0.070

CJD = Creutzfeldt-Jakob Disease, vCJD = new variant Creutzfeldt-Jakob Disease, sCJD = sporadic Creutzfeldt-Jakob Disease, PD = proton density

Tests: Fisher’s exact 2 sided

a There were four cases of familial and seven cases of iatrogenic CJD included in the cohort

b Six non-CJD cases do not have age at death data